OmniVision Entertainment is an entertainment studio and new media platform created to empower comedians, musicians and filmmakers to co-produce, distribute and monetize original, episodic video. Artists create content for the My Damn Channel website and for syndication on the most heavily-trafficked online communities and social networks. The network has aired some of the most successful professionally-produced comedy series on the web, including You Suck at Photoshop, Wainy Days, Horrible People, and videos by Harry Shearer
Helixis, Inc. is a developer of advanced nucleic acid analysis tools that are based on technology spun out of Caltech for research and clinical applications.
Helixis research solutions combine innovative technologies and design, an experienced management team, and most importantly direct feedback from researchers. The company’s mission is to provide high performance instrument systems designed for individual researcher access and use.
(Acquired by Illumina [Nasdaq: ILMN])
Transaction Wireless (TW) is a mobile commerce, payment and one-to-one relationship marketing company enabling a unique link between consumers, retailers and brands via any PC or mobile device leveraging TW’s proprietary technologies. Transaction Wireless’ product portfolio includes wGiftCard, a suite of solutions for the next generation of gift cards and stored value programs delivered to any mobile phone or email; wConnect, a multimedia mobile messaging platform that can extend any brands’ marketing programs to the mobile phone or PC; and wCharge, a small merchant mobile POS credit card terminal.
(Acquired by First Data, Inc.)
OrthAlign, Inc. is committed to providing orthopedic surgeons with user-friendly, cost-effective, surgical navigation products for precise alignment. We believe that our technology will raise the standard of care in joint surgery by making consistent and measurable results accessible to all surgeons, hospitals and patients.
Obalon Therapeutics, Inc. is an early stage company developing a product for the obesity market.
WellTok is fundamentally transforming the way population health managers partner with consumers to optimize their health and get rewarded. Its groundbreaking CaféWell Health Optimization Platform™ organizes the growing spectrum of health and condition management programs, communities, apps and tracking devices. The platform, accessible via web and mobile, drives engagement by providing personalized guidance and leveraging social, gaming and cognitive technologies. Welltok’s novel approach increases revenue, improves operational efficiency and drives healthcare value.
SignNow is the easiest way to sign a document anywhere you go. You can sign your own documents, or invite clients to sign and close contracts faster! SignNow is free to use and simple to get started. (Acquired by Barracuda Networks [NYSE: CUDA])
BabyList is a company that allows you to put anything on your baby registry from any store.
CrowdStrike is a software security company leveraging big data analytics to change the way entities improve informational security.
BioTrace Medical is a medical device company.
Qualaroo is a software company creating solutions to help companies identify and capitalize on more web visitor revenue opportunities.
Pegasus Solar has developed commercial and residential solar mounting systems that enable solar manufacturers to turn their solar module into an integrated module and mounting system. The design reduces raw material, shifts labor from the field to the factory and simplifies logistics throughout the supply chain.
Focal Therapeutics is a medical device company that was established to help surgeons, radiation oncologists, and other clinicians to clearly identify a surgical site through the use of an innovative tissue marker. The company’s BioZorb™ tissue marker is an implantable device placed by surgeons that delineates the site of tissue removal in three dimensions. BioZorb is applicable to virtually all forms of radiation therapy and assists physicians in treatment planning, patient positioning during treatment, and long-term follow-up.